Alembic Pharmaceuticals Ltd
company logo

Alembic Pharmaceuticals Ltd

Alembic Pharma Share Price

Pharmaceuticals
Large Cap

-

0 (0%)


Start Investing in Alembic Pharmaceuticals Ltd

*By signing up you agree to our Terms and Conditions

Alembic Pharmaceuticals Ltd Performance

-

-

-

-


-

-

-

-

-

Alembic Pharmaceuticals Ltd Fundamentals

21,293.68Cr

33.80

4.42

0.13

32.05

1.02%

245.12

i buttonClick here to know more about Fundamentals

Alembic Pharmaceuticals Ltd Financials

Alembic Pharmaceuticals Ltd Financialsright-arrow

Alembic Pharmaceuticals Ltd Shareholding Pattern

Alembic Pharmaceuticals Ltd Delivery and Volume

About Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world. The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in bran

Pranav Amin

2010

APLLTD

NameDesignation
Chirayu R AminChairman & CEO
Rajkumar BahetiDirector (Finance) & CFO
Pranav AminManaging Director
Shaunak AminManaging Director
Archana HingoraniIndependent Director
Ashok BaratIndependent Director
Manisha SarafCompany Sec. & Compli. Officer
Jai S DiwanjiIndependent Director
Manish KejriwalIndependent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Alembic Pharmaceuticals Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Alembic Pharmaceuticals Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Alembic Pharmaceuticals Ltd's share price is ₹1083.55 as of 2024-10-30.
Alembic Pharmaceuticals Ltd's P/E ratio is 33.8 times as of 2024-10-30.
Alembic Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 4.42, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Alembic Pharmaceuticals Ltd's market capitalization is ₹21293.68 Cr as on 2024-10-30.
The current financial records of Alembic Pharmaceuticals Ltd show a 14.3% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Alembic Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹3198.66, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Alembic Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Alembic Pharmaceuticals Ltd's 52-week high and low as of 2024-10-30 are ₹1091.05 and ₹1056.55, respectively.